{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T19:41:43Z","timestamp":1772739703480,"version":"3.50.1"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Taipei Veterans General Hospital, Taiwan","award":["VGHUST101-G1-1-1"],"award-info":[{"award-number":["VGHUST101-G1-1-1"]}]},{"name":"Taipei Veterans General Hospital, Taiwan","award":["VGHUST102-G1-2-1"],"award-info":[{"award-number":["VGHUST102-G1-2-1"]}]},{"name":"Taipei Veterans General Hospital, Taiwan","award":["VGHUST103-G1-4-1"],"award-info":[{"award-number":["VGHUST103-G1-4-1"]}]},{"DOI":"10.13039\/501100001868","name":"National Science Council of Taiwan","doi-asserted-by":"publisher","award":["MOST 103-2314-B-075 -067 -MY3"],"award-info":[{"award-number":["MOST 103-2314-B-075 -067 -MY3"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.pnpbp.2016.02.001","type":"journal-article","created":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T21:45:21Z","timestamp":1454449521000},"page":"219-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Treatment-resistant panic disorder: clinical significance, concept and management"],"prefix":"10.1016","volume":"70","author":[{"given":"Mu-Hong","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9987-022X","authenticated-orcid":false,"given":"Shih-Jen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2016.02.001_bb0005","series-title":"Diagnostic and statistical manual of mental disorders","first-page":"230","author":"American Psychiatric Association","year":"1980"},{"issue":"5 Suppl.","key":"10.1016\/j.pnpbp.2016.02.001_bb0010","first-page":"1","article-title":"Practice guideline for the treatment of patients with panic disorder. Work Group on Panic Disorder","volume":"155","author":"American Psychiatric Association","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.02.001_bb0015","series-title":"Diagnostic and statistical manual of mental disorders","first-page":"119","author":"American Psychiatric Association","year":"2013"},{"issue":"3","key":"10.1016\/j.pnpbp.2016.02.001_bb0020","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.encep.2013.11.002","article-title":"Treatment-resistant anxiety disorders: a literature review of drug therapy strategies","volume":"41","author":"Ammar","year":"2015","journal-title":"Enc\u00e9phale"},{"issue":"6","key":"10.1016\/j.pnpbp.2016.02.001_bb0025","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/da.22277","article-title":"Panic disorder and agoraphobia: an overview and commentary on DSM-5 changes","volume":"31","author":"Asmundson","year":"2014","journal-title":"Depress. Anxiety"},{"issue":"6","key":"10.1016\/j.pnpbp.2016.02.001_bb0030","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/0269881105059253","article-title":"Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology","volume":"19","author":"Baldwin","year":"2005","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2016.02.001_bb0035","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0269881114525674","article-title":"Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive\u2013compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology","volume":"28","author":"Baldwin","year":"2014","journal-title":"J. Psychopharmacol."},{"issue":"Suppl. 22","key":"10.1016\/j.pnpbp.2016.02.001_bb0040","first-page":"29","article-title":"Clinical guidelines for establishing remission in patients with depression and anxiety","volume":"60","author":"Ballenger","year":"1999","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl. 12","key":"10.1016\/j.pnpbp.2016.02.001_bb0045","first-page":"5","article-title":"Treatment of anxiety disorders to remission","volume":"62","author":"Ballenger","year":"2001","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl. 8","key":"10.1016\/j.pnpbp.2016.02.001_bb0050","first-page":"47","article-title":"Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety","volume":"59","author":"Ballenger","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"10 Suppl. 12","key":"10.1016\/j.pnpbp.2016.02.001_bb0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1017\/S1092852900025815","article-title":"Defining response and remission in anxiety disorders: toward an integrated approach","volume":"11","author":"Bandelow","year":"2006","journal-title":"CNS Spectr."},{"issue":"4","key":"10.1016\/j.pnpbp.2016.02.001_bb0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/15622970209150621","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive\u2013compulsive and posttraumatic stress disorders","volume":"3","author":"Bandelow","year":"2002","journal-title":"World J. Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2016.02.001_bb0065","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.4088\/JCP.v67n0914","article-title":"What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?","volume":"67","author":"Bandelow","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2016.02.001_bb0070","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/15622970802465807","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive\u2013compulsive and post-traumatic stress disorders \u2014 first revision","volume":"9","author":"Bandelow","year":"2008","journal-title":"World J. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2016.02.001_bb0075","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1037\/a0031178","article-title":"Influence of trauma history on panic and posttraumatic stress disorder in returning veterans","volume":"10","author":"Barrera","year":"2013","journal-title":"Psychol. Serv."},{"issue":"1","key":"10.1016\/j.pnpbp.2016.02.001_bb0080","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1017\/S0033291709005625","article-title":"The 2-year prognosis of panic episodes in the general population","volume":"40","author":"Batelaan","year":"2010","journal-title":"Psychol. Med."},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2016.02.001_bb0085","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jad.2009.05.003","article-title":"The course of panic attacks in individuals with panic disorder and subthreshold panic disorder: a population-based study","volume":"121","author":"Batelaan","year":"2010","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.pnpbp.2016.02.001_bb0090","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.janxdis.2013.12.003","article-title":"Anxiety disorders and onset of cardiovascular disease: the differential impact of panic, phobias and worry","volume":"28","author":"Batelaan","year":"2014","journal-title":"J. Anxiety Disord."},{"issue":"4","key":"10.1016\/j.pnpbp.2016.02.001_bb0095","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.janxdis.2012.02.008","article-title":"Contextual factors and anxiety in minority and European American youth presenting for treatment across two urban university clinics","volume":"26","author":"Beidas","year":"2012","journal-title":"J. Anxiety Disord."},{"issue":"3","key":"10.1016\/j.pnpbp.2016.02.001_bb0100","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0165-1781(91)90068-Z","article-title":"A high risk study of young children of parents with panic disorder and agoraphobia with and without comorbid major depression","volume":"37","author":"Biederman","year":"1991","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2016.02.001_bb0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1176\/appi.ajp.158.1.49","article-title":"Patterns of psychopathology and dysfunction in high-risk children of parents with panic disorder and major depression","volume":"158","author":"Biederman","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2016.02.001_bb0110","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/da.20314","article-title":"Anxiety disorders and risk for suicide attempts: findings from the Baltimore Epidemiologic Catchment area follow-up study","volume":"25","author":"Bolton","year":"2008","journal-title":"Depress. Anxiety"},{"issue":"2","key":"10.1016\/j.pnpbp.2016.02.001_bb0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF02193525","article-title":"Suicidal ideation and suicide attempts: comorbidity with depression, anxiety disorders, and substance abuse disorder","volume":"244","author":"Bronisch","year":"1994","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"10","key":"10.1016\/j.pnpbp.2016.02.001_bb0120","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1176\/ajp.153.10.1293","article-title":"Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders","volume":"153","author":"Brown","year":"1996","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2016.02.001_bb0125","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1176\/appi.ajp.162.6.1179","article-title":"Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study","volume":"162","author":"Bruce","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2016.02.001_bb0130","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.mp.4001852","article-title":"Treatment-resistant anxiety disorders","volume":"11","author":"Bystritsky","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.02.001_bb0135","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.3389\/fpsyg.2015.01202","article-title":"Investigating the relationship between interoceptive accuracy, interoceptive awareness, and emotional susceptibility","volume":"6","author":"Cali","year":"2015","journal-title":"Front. Psychol."},{"issue":"6","key":"10.1016\/j.pnpbp.2016.02.001_bb0140","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2174\/138161210790883868","article-title":"Low grade inflammation as a common pathogenetic denominator in age-related diseases: novel drug targets for anti-ageing strategies and successful ageing achievement","volume":"16","author":"Candore","year":"2010","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"10.1016\/j.pnpbp.2016.02.001_bb0145","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1017\/S1461145712000776","article-title":"Gender-specific abnormalities in the serotonin transporter system in panic disorder","volume":"16","author":"Cannon","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2016.02.001_bb0150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-3999(97)00137-2","article-title":"Panic disorder and asthma: causes, effects and research implications","volume":"44","author":"Carr","year":"1998","journal-title":"J. Psychosom. Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2016.02.001_bb0155","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-0447.2010.01541.x","article-title":"Patterns of psychiatric and physical comorbidities associated with panic disorder in a nationwide population-based study in Taiwan","volume":"123","author":"Chen","year":"2011","journal-title":"Acta Psychiatr. Scand."},{"issue":"3","key":"10.1016\/j.pnpbp.2016.02.001_bb0160","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00737-005-0111-y","article-title":"Sex differences in clinical presentation and response in panic disorder: pooled data from sertraline treatment studies","volume":"9","author":"Clayton","year":"2006","journal-title":"Arch. Womens Ment. Health"},{"issue":"2","key":"10.1016\/j.pnpbp.2016.02.001_bb0165","first-page":"176","article-title":"Combined antidepressants and CBT for panic disorder with agoraphobia","volume":"33","author":"Coupland","year":"2008","journal-title":"J. Psychiatry Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2016.02.001_bb0170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/(SICI)1522-7154(1996)2:1<13::AID-ANXI2>3.0.CO;2-E","article-title":"Long-term course and outcome in panic disorder: a naturalistic follow-up study","volume":"2","author":"Cowley","year":"1996","journal-title":"Anxiety"},{"issue":"3","key":"10.1016\/j.pnpbp.2016.02.001_bb0175","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1017\/S1092852900010002","article-title":"Ziprasidone as an augmenting agent in the treatment of anxiety-spectrum disorders","volume":"10","author":"Crane","year":"2005","journal-title":"CNS Spectr."},{"issue":"2","key":"10.1016\/j.pnpbp.2016.02.001_bb0180","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/da.20654","article-title":"Panic disorder: a review of DSM-IV panic disorder and proposals for DSM-V","volume":"27","author":"Craske","year":"2010","journal-title":"Depress. Anxiety"},{"issue":"2 Pt 2","key":"10.1016\/j.pnpbp.2016.02.001_bb0185","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/15622970903178176","article-title":"The fear circuitry in panic disorder and its modulation by cognitive-behaviour therapy interventions","volume":"11","author":"de Carvalho","year":"2010","journal-title":"World J. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2016.02.001_bb0190","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1586\/ern.09.161","article-title":"Current findings of fMRI in panic disorder: contributions for the fear neurocircuitry and CBT effects","volume":"10","author":"de Carvalho","year":"2010","journal-title":"Expert. Rev. Neurother."},{"issue":"3","key":"10.1016\/j.pnpbp.2016.02.001_bb0195","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1017\/S1461145705005869","article-title":"Association of the functional \u22121019C\/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder","volume":"9","author":"Domschke","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2016.02.001_bb0200","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pscychresns.2007.04.016","article-title":"Influence of the catechol-O-methyltransferase val158met genotype on amygdala and prefrontal cortex emotional processing in panic disorder","volume":"163","author":"Domschke","year":"2008","journal-title":"Psychiatry Res."},{"issue":"Suppl. 15","key":"10.1016\/j.pnpbp.2016.02.001_bb0205","first-page":"40","article-title":"Establishment of remission criteria for anxiety disorders","volume":"64","author":"Doyle","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2016.02.001_bb0210","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000099842","article-title":"Which panic disorder patients benefit from which treatment: cognitive therapy or antidepressants?","volume":"76","author":"Dusseldorp","year":"2007","journal-title":"Psychother. Psychosom."},{"issue":"2","key":"10.1016\/j.pnpbp.2016.02.001_bb0215","first-page":"154","article-title":"Phaeochromocytoma \u2014 a classic (but easily forgotten) cause of anxiety","volume":"14","author":"Edge","year":"2011","journal-title":"Afr. J. Psychiatry (Johannesbg)"},{"issue":"2","key":"10.1016\/j.pnpbp.2016.02.001_bb0220","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","article-title":"Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes","volume":"105","author":"Esser","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"5","key":"10.1016\/j.pnpbp.2016.02.001_bb0225","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.genhosppsych.2005.05.012","article-title":"A cognitive therapy conceptualization of panic disorder exacerbated by interferon treatment","volume":"27","author":"Farber","year":"2005","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2016.02.001_bb0230","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.brat.2013.06.002","article-title":"Mechanisms of change in cognitive behaviour therapy for panic disorder: the role of panic self-efficacy and catastrophic misinterpretations","volume":"51","author":"Fentz","year":"2013","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.pnpbp.2016.02.001_bb0235","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brat.2014.06.003","article-title":"The mediational role of panic self-efficacy in cognitive behavioral therapy for panic disorder: a systematic review and meta-analysis","volume":"60","author":"Fentz","year":"2014","journal-title":"Behav. Res. Ther."},{"issue":"3","key":"10.1016\/j.pnpbp.2016.02.001_bb0240","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1192\/bjp.bp.114.149880","article-title":"Common and disorder-specific neural responses to emotional faces in generalised anxiety, social anxiety and panic disorders","volume":"206","author":"Fonzo","year":"2015","journal-title":"Br. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2016.02.001_bb0245","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4088\/PCC.v09n0301","article-title":"Characteristics and course of panic disorder and panic disorder with agoraphobia in primary care patients","volume":"9","author":"Francis","year":"2007","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2016.02.001_bb0250","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2174\/1871527313666140612125028","article-title":"Current pharmacological interventions in panic disorder","volume":"13","author":"Freire","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"11","key":"10.1016\/j.pnpbp.2016.02.001_bb0255","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.brat.2013.09.001","article-title":"Mechanisms of change in cognitive behavioral therapy for panic disorder: the unique effects of self-efficacy and anxiety sensitivity","volume":"51","author":"Gallagher","year":"2013","journal-title":"Behav. Res. Ther."},{"issue":"9","key":"10.1016\/j.pnpbp.2016.02.001_bb0260","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.4088\/JCP.v67n0902","article-title":"Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review","volume":"67","author":"Gao","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl. 6","key":"10.1016\/j.pnpbp.2016.02.001_bb0265","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4088\/JCP.8133su1c.02","article-title":"Identifying difficult-to-treat depression: differential diagnosis, subtypes, and comorbidities","volume":"70","author":"Gaynes","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2016.02.001_bb0270","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/155005941104200108","article-title":"Amygdalar hyperactivity, a fear-related link between panic disorder and mesiotemporal epilepsy","volume":"42","author":"Gerez","year":"2011","journal-title":"Clin. EEG Neurosci."},{"issue":"6","key":"10.1016\/j.pnpbp.2016.02.001_bb0275","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1037\/a0025933","article-title":"Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS","volume":"79","author":"Ginsburg","year":"2011","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.pnpbp.2016.02.001_bb0280","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12991-015-0064-0","article-title":"A controlled trial of quetiapine XR coadministration treatment of SSRI-resistant panic disorder","volume":"14","author":"Goddard","year":"2015","journal-title":"Ann. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2016.02.001_bb0285","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jamapsychiatry.2014.1741","article-title":"Predicting treatment response to cognitive behavioral therapy in panic disorder with agoraphobia by integrating local neural information","volume":"72","author":"Hahn","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2016.02.001_bb0290","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4306\/pi.2015.12.1.112","article-title":"Evidence for association between the brain-derived neurotrophic factor gene and panic disorder: a novel haplotype analysis","volume":"12","author":"Han","year":"2015","journal-title":"Psychiatry Investig."},{"issue":"Suppl. 10","key":"10.1016\/j.pnpbp.2016.02.001_bb0295","first-page":"3","article-title":"Panic disorder: diagnosis, epidemiology, and clinical course","volume":"57","author":"Hirschfeld","year":"1996","journal-title":"J. Clin. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2016.02.001_bb0300","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.psychres.2005.08.026","article-title":"Psychopathology in the young offspring of parents with bipolar disorder: a controlled pilot study","volume":"145","author":"Hirshfeld-Becker","year":"2006","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2016.02.001_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cpp.1934","article-title":"Cognitive and guided mastery therapies for panic disorder with agoraphobia: 18-year long-term outcome and predictors of long-term change","volume":"23","author":"Hoffart","year":"2016","journal-title":"Clin. Psychol. Psychother."},{"issue":"2","key":"10.1016\/j.pnpbp.2016.02.001_bb0310","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1521\/ijct.2009.2.2.160","article-title":"Is it beneficial to add pharmacotherapy to cognitive-behavioral therapy when treating anxiety disorders? A meta-analytic review","volume":"2","author":"Hofmann","year":"2009","journal-title":"Int. J. Cogn. Ther."},{"issue":"6","key":"10.1016\/j.pnpbp.2016.02.001_bb0315","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1017\/S109285290001676X","article-title":"Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder","volume":"13","author":"Hoge","year":"2008","journal-title":"CNS Spectr."},{"issue":"5","key":"10.1016\/j.pnpbp.2016.02.001_bb0320","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/da.20564","article-title":"Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder","volume":"26","author":"Hoge","year":"2009","journal-title":"Depress. Anxiety"},{"issue":"4","key":"10.1016\/j.pnpbp.2016.02.001_bb0325","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuroimage.2012.03.019","article-title":"Brain activation during anticipation of interoceptive threat","volume":"61","author":"Holtz","year":"2012","journal-title":"NeuroImage"},{"issue":"8","key":"10.1016\/j.pnpbp.2016.02.001_bb0330","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1586\/ern.10.76","article-title":"Genetics of panic disorder: focus on association studies and therapeutic perspectives","volume":"10","author":"Jacob","year":"2010","journal-title":"Expert. Rev. Neurother."},{"issue":"10","key":"10.1016\/j.pnpbp.2016.02.001_bb0335","first-page":"917","article-title":"The association between anxiety disorders and suicidal behaviors: a systematic review and meta-analysis","volume":"30","author":"Kanwar","year":"2013","journal-title":"Depress. Anxiety"},{"issue":"22","key":"10.1016\/j.pnpbp.2016.02.001_bb0340","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1056\/NEJMcp052466","article-title":"Clinical practice. Panic disorder","volume":"354","author":"Katon","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"6 Suppl. 2","key":"10.1016\/j.pnpbp.2016.02.001_bb0345","doi-asserted-by":"crossref","first-page":"6S","DOI":"10.1097\/00004714-199812001-00003","article-title":"The long-term course of panic disorder and its predictors","volume":"18","author":"Katschnig","year":"1998","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2016.02.001_bb0350","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4088\/JCP.13m08922","article-title":"Prognostic subgroups for remission and response in the Coordinated Anxiety Learning and Management (CALM) trial","volume":"76","author":"Kelly","year":"2015","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2016.02.001_bb0355","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00043764-200103000-00009","article-title":"The effects of chronic medical conditions on work loss and work cutback","volume":"43","author":"Kessler","year":"2001","journal-title":"J. Occup. Environ. Med."},{"issue":"6","key":"10.1016\/j.pnpbp.2016.02.001_bb0360","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2016.02.001_bb0365","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2016.02.001_bb0370","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/archpsyc.63.4.415","article-title":"The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication","volume":"63","author":"Kessler","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2016.02.001_bb0375","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pnpbp.2004.10.008","article-title":"Relationship between anxiety and thyroid function in patients with panic disorder","volume":"29","author":"Kikuchi","year":"2005","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2016.02.001_bb0380","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/da.20603","article-title":"Subtypes of panic attacks: a critical review of the empirical literature","volume":"26","author":"Kircanski","year":"2009","journal-title":"Depress. Anxiety"},{"issue":"9149","key":"10.1016\/j.pnpbp.2016.02.001_bb0385","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(05)74898-4","article-title":"Panic disorder","volume":"353","author":"Klein","year":"1999","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.pnpbp.2016.02.001_bb0390","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.pnpbp.2005.04.010","article-title":"Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group cognitive behavioral therapy","volume":"29","author":"Kobayashi","year":"2005","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2016.02.001_bb0395","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000078845","article-title":"Reduced anxiety level by therapeutic interventions and cell-mediated immunity in panic disorder patients","volume":"73","author":"Koh","year":"2004","journal-title":"Psychother. Psychosom."},{"issue":"Suppl. 8","key":"10.1016\/j.pnpbp.2016.02.001_bb0400","first-page":"11","article-title":"The impact of comorbidity on the treatment of panic disorder","volume":"59","author":"Lecrubier","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.02.001_bb0405","first-page":"CD009083","article-title":"Repetitive transcranial magnetic stimulation (rTMS) for panic disorder in adults","volume":"9","author":"Li","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"Suppl. 13","key":"10.1016\/j.pnpbp.2016.02.001_bb0410","first-page":"5","article-title":"Panic disorder as a chronic illness","volume":"58","author":"Liebowitz","year":"1997","journal-title":"J. Clin. Psychiatry"},{"issue":"11","key":"10.1016\/j.pnpbp.2016.02.001_bb0415","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1176\/appi.ajp.2013.12111484","article-title":"Neural substrates of treatment response to cognitive-behavioral therapy in panic disorder with agoraphobia","volume":"170","author":"Lueken","year":"2013","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2016.02.001_bb0420","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00702-014-1311-2","article-title":"Therapygenetics: anterior cingulate cortex-amygdala coupling is associated with 5-HTTLPR and treatment response in panic disorder with agoraphobia","volume":"122","author":"Lueken","year":"2015","journal-title":"J. Neural Transm."},{"issue":"9904","key":"10.1016\/j.pnpbp.2016.02.001_bb0425","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(13)61781-X","article-title":"The global burden of drug use and mental disorders","volume":"382","author":"Lynskey","year":"2013","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.pnpbp.2016.02.001_bb0430","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/da.22238","article-title":"Critical review of outcome research on interpersonal psychotherapy for anxiety disorders","volume":"31","author":"Markowitz","year":"2014","journal-title":"Depress. Anxiety"},{"issue":"3","key":"10.1016\/j.pnpbp.2016.02.001_bb0435","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.psc.2009.05.005","article-title":"Empirically supported treatments for panic disorder","volume":"32","author":"McHugh","year":"2009","journal-title":"Psychiatr. Clin. N. Am."},{"issue":"2","key":"10.1016\/j.pnpbp.2016.02.001_bb0440","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.neuroimage.2009.09.040","article-title":"A meta-analysis of instructed fear studies: implications for conscious appraisal of threat","volume":"49","author":"Mechias","year":"2010","journal-title":"NeuroImage"},{"issue":"10","key":"10.1016\/j.pnpbp.2016.02.001_bb0445","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.brat.2008.07.002","article-title":"Anticipation of interoceptive threat in highly anxiety sensitive persons","volume":"46","author":"Melzig","year":"2008","journal-title":"Behav. Res. Ther."},{"issue":"Suppl. 2","key":"10.1016\/j.pnpbp.2016.02.001_bb0450","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1590\/S1516-44462007000600004","article-title":"Treatment-resistant anxiety disorders: social phobia, generalized anxiety disorder and panic disorder","volume":"29","author":"Menezes","year":"2007","journal-title":"Rev. Bras. Psiquiatr."},{"issue":"2","key":"10.1016\/j.pnpbp.2016.02.001_bb0455","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.beth.2011.08.002","article-title":"Coping skills and exposure therapy in panic disorder and agoraphobia: latest advances and future directions","volume":"43","author":"Meuret","year":"2012","journal-title":"Behav. Ther."},{"issue":"2","key":"10.1016\/j.pnpbp.2016.02.001_bb0460","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1124\/mol.107.038232","article-title":"Brain-derived neurotrophic factor: linking fear learning to memory consolidation","volume":"72","author":"Monfils","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pnpbp.2016.02.001_bb0465","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jad.2014.06.021","article-title":"Risk factors for the onset of panic and generalised anxiety disorders in the general adult population: a systematic review of cohort studies","volume":"168","author":"Moreno-Peral","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2016.02.001_bb0470","first-page":"1","article-title":"Emerging drugs for the treatment of anxiety","author":"Murrough","year":"2015","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"3","key":"10.1016\/j.pnpbp.2016.02.001_bb0475","first-page":"353","article-title":"Clonazepam for the treatment of panic disorder","volume":"14","author":"Nardi","year":"2013","journal-title":"Curr. Drug Targets"},{"issue":"1","key":"10.1016\/j.pnpbp.2016.02.001_bb0480","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.psychres.2013.03.006","article-title":"Longitudinal course of panic disorder with and without agoraphobia using the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)","volume":"208","author":"Nay","year":"2013","journal-title":"Psychiatry Res."},{"issue":"9","key":"10.1016\/j.pnpbp.2016.02.001_bb0485","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/da.20674","article-title":"The relationship between anxiety disorders and suicide attempts: findings from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"27","author":"Nepon","year":"2010","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.pnpbp.2016.02.001_bb0490","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-244X-7-70","article-title":"Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder","volume":"7","author":"Noda","year":"2007","journal-title":"BMC Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2016.02.001_bb0495","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000353198","article-title":"Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis","volume":"82","author":"Offidani","year":"2013","journal-title":"Psychother. Psychosom."},{"issue":"4","key":"10.1016\/j.pnpbp.2016.02.001_bb0500","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1037\/0022-006X.68.4.556","article-title":"Empirically supported treatments for panic disorder: costs, benefits, and stepped care","volume":"68","author":"Otto","year":"2000","journal-title":"J. Consult. Clin. Psychol."},{"issue":"3","key":"10.1016\/j.pnpbp.2016.02.001_bb0505","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.nlm.2009.12.003","article-title":"Late expression of brain-derived neurotrophic factor in the amygdala is required for persistence of fear memory","volume":"93","author":"Ou","year":"2010","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.pnpbp.2016.02.001_bb0510","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1471-244X-11-200","article-title":"Efficacy of exposure versus cognitive therapy in anxiety disorders: systematic review and meta-analysis","volume":"11","author":"Ougrin","year":"2011","journal-title":"BMC Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2016.02.001_bb0515","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/mp.2015.92","article-title":"Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder","volume":"20","author":"Papakostas","year":"2015","journal-title":"Mol. Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2016.02.001_bb0520","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/da.22379","article-title":"Identifying panic disorder subtypes using factor mixture modeling","volume":"32","author":"Pattyn","year":"2015","journal-title":"Depress. Anxiety"},{"issue":"4","key":"10.1016\/j.pnpbp.2016.02.001_bb0525","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1517\/14728214.2011.628313","article-title":"Emerging drugs for panic disorder","volume":"16","author":"Perna","year":"2011","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"4","key":"10.1016\/j.pnpbp.2016.02.001_bb0530","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1517\/13543784.2014.996286","article-title":"Novel investigational therapeutics for panic disorder","volume":"24","author":"Perna","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"1","key":"10.1016\/j.pnpbp.2016.02.001_bb0535","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4088\/JCP.v67n0119","article-title":"Children of currently depressed mothers: a STAR*D ancillary study","volume":"67","author":"Pilowsky","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2016.02.001_bb0540","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2190\/PM.41.4.f","article-title":"Anxiety disorders, hypertension, and cardiovascular risk: a review","volume":"41","author":"Player","year":"2011","journal-title":"Int. J. Psychiatry Med."},{"issue":"2","key":"10.1016\/j.pnpbp.2016.02.001_bb0545","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pscychresns.2015.05.013","article-title":"Neural correlates of anxiety sensitivity in panic disorder: a functional magnetic resonance imaging study","volume":"233","author":"Poletti","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2016.02.001_bb0550","first-page":"11","article-title":"Long-term management of panic disorder","volume":"51","author":"Pollack","year":"1990","journal-title":"J. Clin. Psychiatry"},{"issue":"8 Suppl. 1","key":"10.1016\/j.pnpbp.2016.02.001_bb0555","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1017\/S109285290000691X","article-title":"WCA recommendations for the long-term treatment of panic disorder","volume":"8","author":"Pollack","year":"2003","journal-title":"CNS Spectr."},{"key":"10.1016\/j.pnpbp.2016.02.001_bb0560","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-244X-9-25","article-title":"A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind study","volume":"9","author":"Prosser","year":"2009","journal-title":"BMC Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2016.02.001_bb0565","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jad.2011.01.006","article-title":"Age of onset, clinical characteristics, and 15-year course of anxiety disorders in a prospective, longitudinal, observational study","volume":"132","author":"Ramsawh","year":"2011","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.pnpbp.2016.02.001_bb0570","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1463-1326.2006.00594.x","article-title":"Cardiovascular metabolic syndrome \u2014 an interplay of, obesity, inflammation, diabetes and coronary heart disease","volume":"9","author":"Rana","year":"2007","journal-title":"Diabetes Obes. Metab."},{"issue":"20","key":"10.1016\/j.pnpbp.2016.02.001_bb0575","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1523\/JNEUROSCI.5654-03.2004","article-title":"Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning","volume":"24","author":"Rattiner","year":"2004","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.pnpbp.2016.02.001_bb0580","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jad.2013.05.042","article-title":"Complementary and alternative therapies as add-on to pharmacotherapy for mood and anxiety disorders: a systematic review","volume":"150","author":"Ravindran","year":"2013","journal-title":"J. Affect. Disord."},{"issue":"7","key":"10.1016\/j.pnpbp.2016.02.001_bb0585","doi-asserted-by":"crossref","first-page":"839","DOI":"10.4088\/JCP.10r06218blu","article-title":"The pharmacologic treatment of anxiety disorders: a review of progress","volume":"71","author":"Ravindran","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2016.02.001_bb0590","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ajmg.b.32085","article-title":"Meta-analysis argues for a female-specific role of MAOA-uVNTR in panic disorder in four European populations","volume":"159B","author":"Reif","year":"2012","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"1","key":"10.1016\/j.pnpbp.2016.02.001_bb0595","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/mp.2012.172","article-title":"MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy","volume":"19","author":"Reif","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.02.001_bb0600","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.brat.2014.07.017","article-title":"Predicting rapid response to cognitive-behavioural treatment for panic disorder: the role of hippocampus, insula, and dorsolateral prefrontal cortex","volume":"62","author":"Reinecke","year":"2014","journal-title":"Behav. Res. Ther."},{"issue":"3","key":"10.1016\/j.pnpbp.2016.02.001_bb0605","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1017\/S0033291711001425","article-title":"A latent class approach to the external validation of respiratory and non-respiratory panic subtypes","volume":"42","author":"Roberson-Nay","year":"2012","journal-title":"Psychol. Med."},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2016.02.001_bb0610","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jad.2010.08.025","article-title":"CBT for pharmacotherapy non-remitters\u2014a systematic review of a next-step strategy","volume":"129","author":"Rodrigues","year":"2011","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.pnpbp.2016.02.001_bb0615","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.psyneuen.2011.12.015","article-title":"Acute and chronic stress induced changes in sensitivity of peripheral inflammatory pathways to the signals of multiple stress systems \u2014 2011 Curt Richter Award Winner","volume":"37","author":"Rohleder","year":"2012","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1016\/j.pnpbp.2016.02.001_bb0620","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/PSY.0000000000000049","article-title":"Stimulation of systemic low-grade inflammation by psychosocial stress","volume":"76","author":"Rohleder","year":"2014","journal-title":"Psychosom. Med."},{"issue":"7","key":"10.1016\/j.pnpbp.2016.02.001_bb0625","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/da.20829","article-title":"Relative effects of CBT and pharmacotherapy in depression versus anxiety: is medication somewhat better for depression, and CBT somewhat better for anxiety?","volume":"28","author":"Roshanaei-Moghaddam","year":"2011","journal-title":"Depress. Anxiety"},{"issue":"Suppl. 4","key":"10.1016\/j.pnpbp.2016.02.001_bb0630","first-page":"16","article-title":"Understanding and treating panic disorder in the primary care setting","volume":"66","author":"Roy-Byrne","year":"2005","journal-title":"J. Clin. Psychiatry"},{"issue":"9540","key":"10.1016\/j.pnpbp.2016.02.001_bb0635","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(06)69418-X","article-title":"Panic disorder","volume":"368","author":"Roy-Byrne","year":"2006","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.pnpbp.2016.02.001_bb0640","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00228-009-0633-8","article-title":"Genetic and pharmacokinetic factors affecting the initial pharmacotherapeutic effect of paroxetine in Japanese patients with panic disorder","volume":"65","author":"Saeki","year":"2009","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2016.02.001_bb0645","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0145445500242001","article-title":"Anxiety in ethnic minority youth. Methodological and conceptual issues and review of the literature","volume":"24","author":"Safren","year":"2000","journal-title":"Behav. Modif."},{"issue":"11","key":"10.1016\/j.pnpbp.2016.02.001_bb0650","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/archpsyc.62.11.1249","article-title":"Anxiety disorders and risk for suicidal ideation and suicide attempts: a population-based longitudinal study of adults","volume":"62","author":"Sareen","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2016.02.001_bb0655","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000285045","article-title":"Predictors and outcome in panic disorder: a 2-year prospective follow-up study","volume":"30","author":"Scheibe","year":"1997","journal-title":"Psychopathology"},{"issue":"3","key":"10.1016\/j.pnpbp.2016.02.001_bb0660","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jad.2008.10.005","article-title":"Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety","volume":"115","author":"Sheehan","year":"2009","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.pnpbp.2016.02.001_bb0665","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1037\/a0034382","article-title":"Two-year course of generalized anxiety disorder, social anxiety disorder, and panic disorder in a longitudinal sample of African American adults","volume":"81","author":"Sibrava","year":"2013","journal-title":"J. Consult. Clin. Psychol."},{"issue":"11","key":"10.1016\/j.pnpbp.2016.02.001_bb0670","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.4088\/JCP.08m04485blu","article-title":"Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial","volume":"70","author":"Simon","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2016.02.001_bb0675","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/da.22287","article-title":"Personality disorders and the persistence of anxiety disorders in a nationally representative sample","volume":"31","author":"Skodol","year":"2014","journal-title":"Depress. Anxiety"},{"issue":"1","key":"10.1016\/j.pnpbp.2016.02.001_bb0680","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/head.12004","article-title":"Panic disorder and migraine: comorbidity, mechanisms, and clinical implications","volume":"53","author":"Smitherman","year":"2013","journal-title":"Headache"},{"issue":"Suppl. 6","key":"10.1016\/j.pnpbp.2016.02.001_bb0685","first-page":"16","article-title":"Treatment-resistant depression","volume":"67","author":"Souery","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2016.02.001_bb0690","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1017\/S1092852900022355","article-title":"Unresolved questions about treatment-resistant anxiety disorders","volume":"9","author":"Stein","year":"2004","journal-title":"CNS Spectr."},{"issue":"3","key":"10.1016\/j.pnpbp.2016.02.001_bb0695","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.psyneuen.2009.07.013","article-title":"Acute exercise ameliorates reduced brain-derived neurotrophic factor in patients with panic disorder","volume":"35","author":"Strohle","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2016.02.001_bb0700","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fnint.2013.00055","article-title":"Brain-Derived Neurotrophic Factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysis","volume":"7","author":"Suliman","year":"2013","journal-title":"Front. Integr. Neurosci."},{"issue":"2","key":"10.1016\/j.pnpbp.2016.02.001_bb0705","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0887-6185(02)00183-4","article-title":"The long-term course of panic disorder\u2013an 11year follow-up","volume":"17","author":"Swoboda","year":"2003","journal-title":"J. Anxiety Disord."},{"issue":"6","key":"10.1016\/j.pnpbp.2016.02.001_bb0710","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1037\/a0021067","article-title":"Catastrophic misinterpretations as a predictor of symptom change during treatment for panic disorder","volume":"78","author":"Teachman","year":"2010","journal-title":"J. Consult. Clin. Psychol."},{"issue":"10","key":"10.1016\/j.pnpbp.2016.02.001_bb0715","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/da.22203","article-title":"Anxiety disorders are independently associated with suicide ideation and attempts: propensity score matching in two epidemiological samples","volume":"30","author":"Thibodeau","year":"2013","journal-title":"Depress. Anxiety"},{"issue":"4","key":"10.1016\/j.pnpbp.2016.02.001_bb0720","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0022-3999(02)00429-4","article-title":"Hypothalamic\u2013pituitary\u2013adrenal axis, neuroendocrine factors and stress","volume":"53","author":"Tsigos","year":"2002","journal-title":"J. Psychosom. Res."},{"issue":"5","key":"10.1016\/j.pnpbp.2016.02.001_bb0725","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4088\/JCP.08m04681blu","article-title":"A randomized trial of cognitive-behavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia: treatment results through 1-year follow-up","volume":"71","author":"van Apeldoorn","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2016.02.001_bb0730","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jad.2013.04.012","article-title":"Rate of improvement during and across three treatments for panic disorder with or without agoraphobia: cognitive behavioral therapy, selective serotonin reuptake inhibitor or both combined","volume":"150","author":"Van Apeldoorn","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2016.02.001_bb0735","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1038\/tp.2013.27","article-title":"Anxiety disorders and inflammation in a large adult cohort","volume":"3","author":"Vogelzangs","year":"2013","journal-title":"Transl. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2016.02.001_bb0740","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archpsyc.62.6.603","article-title":"Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication","volume":"62","author":"Wang","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2016.02.001_bb0745","first-page":"177","article-title":"Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization's World Mental Health Survey Initiative","volume":"6","author":"Wang","year":"2007","journal-title":"World Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2016.02.001_bb0750","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/hup.2419","article-title":"The potential role of atypical antipsychotics in the treatment of panic disorder","volume":"29","author":"Wang","year":"2014","journal-title":"Hum. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2016.02.001_bb0755","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1037\/0022-006X.69.6.875","article-title":"A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapies","volume":"69","author":"Westen","year":"2001","journal-title":"J. Consult. Clin. Psychol."},{"issue":"9904","key":"10.1016\/j.pnpbp.2016.02.001_bb0760","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","article-title":"Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010","volume":"382","author":"Whiteford","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.pnpbp.2016.02.001_bb0765","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000116608","article-title":"Agoraphobia and panic. Prospective-longitudinal relations suggest a rethinking of diagnostic concepts","volume":"77","author":"Wittchen","year":"2008","journal-title":"Psychother. Psychosom."},{"issue":"4","key":"10.1016\/j.pnpbp.2016.02.001_bb0770","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1254\/jphs.91.267","article-title":"Brain-derived neurotrophic factor\/TrkB signaling in memory processes","volume":"91","author":"Yamada","year":"2003","journal-title":"J. Pharmacol. Sci."},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2016.02.001_bb0775","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jad.2009.09.007","article-title":"Early response to selective serotonin reuptake inhibitors in panic disorder is associated with a functional 5-HT1A receptor gene polymorphism","volume":"123","author":"Yevtushenko","year":"2010","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.pnpbp.2016.02.001_bb0780","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/da.10106","article-title":"Chronicity, relapse, and illness\u2013course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8years of follow-up","volume":"17","author":"Yonkers","year":"2003","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.pnpbp.2016.02.001_bb0785","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12993-015-0058-8","article-title":"The roles of interoceptive sensitivity and metacognitive interoception in panic","volume":"11","author":"Yoris","year":"2015","journal-title":"Behav. Brain Funct."},{"issue":"8","key":"10.1016\/j.pnpbp.2016.02.001_bb0790","first-page":"1477","article-title":"What to do when SSRIs fail: eight strategies for optimizing treatment of panic disorder","volume":"66","author":"Zamorski","year":"2002","journal-title":"Am. Fam. Physician"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858461630015X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858461630015X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T15:55:59Z","timestamp":1537026959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027858461630015X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":158,"alternative-id":["S027858461630015X"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2016.02.001","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment-resistant panic disorder: clinical significance, concept and management","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2016.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}